Share | Page 30 of 38 | SpiritIndia.com

Acromegaly :: Options improving for patients with acromegaly and gigantism – endocrinology expert

Scientific, technological and medical advances made in the past two decades are leading to more definitive diagnoses, earlier and more effective treatment options and better outcomes for patients suffering from a condition called acromegaly, according to an article published in today’s issue of the New England Journal of Medicine and authored by a specialist in endocrinology at Cedars-Sinai Medical Center.

Dental :: Dental crowns reveal the diet of a species

According to recent research, the complexity of tooth surfaces reveals the diet of a species. Scientists at the University of Helsinki’s Institute of Biotechnology and Department of Geology showed that the more complex the surface of an animal’s teeth, the greater the share of vegetables in its diet. For instance, the teeth of carnivores and rodents differ in almost every aspect, but if a carnivore and a rodent eat similar food, their teeth are equally complex. The results were published in Nature.

Retirement :: Federal Workers Share Poor Retirement Planning With All Workers

Survey Finds Federal Workers Share Poor Retirement Planning With All Workers, but Have More Savings:

Healthcare :: Congressional Action Strengthens Internal Medicine ACP Says

Saturday?s Congressional action to avert Medicare payment cuts to physicians will work to strengthen the future of internal medicine, the American College of Physicians (ACP) said today in a statement of appreciation to lawmakers.

Hepatitis :: Abbott, Enanta to Develop and Commercialize HCV Protease Inhibitors

Abbott and Enanta Pharmaceuticals announced today that the companies have signed a worldwide agreement to develop and commercialize hepatitis C virus (HCV) NS3 and NS3/4A protease inhibitors. Enanta has discovered several HCV protease inhibitors that have demonstrated attractive efficacy and pharmacokinetic profiles in pre-clinical studies.

Multiple Sclerosis :: Tysabri treatment to Scots with multiple sclerosis (MS)

The MS Trust is dismayed by the SMC decision to deny this treatment to around 1,000 Scots living with rapidly deteriorating MS, by banning the drug Tysabri (natalizumab).

Tata Steel, Corus get US anti-trust authorities’ approval

Indian steel major Tata Steel has received approval from US anti-trust authorities for the proposed acquisition of Anglo-Dutch firm Corus Group Plc.

Climate :: Climate experts search for answers in the oceans

By absorbing half of the carbon dioxide emitted into the atmosphere, the oceans have a profound influence on climate. However, their ability to take up this carbon dioxide might be impaired as a result of climate change. To determine their response to global warming, ESA has backed two projects that provide systematic data on key oceanic variables — color and temperature.

Drug Addiction :: Tajikistan inflicted by the trafficking of drugs

Central Asia’s poorest county is also one of the world’s leading transit routes for heroin, opium and other drugs from Afghanistan.